-+ 0.00%
-+ 0.00%
-+ 0.00%

TENAYA THERAPEUTICS ANNOUNCES LATE-BREAKING ORAL PRESENTATION OF NEW CLINICAL DATA FROM RIDGE™-1 PHASE 1B/2 CLINICAL TRIAL OF TN-401 GENE THERAPY IN ADULTS WITH PKP2-ASSOCIATED ARVC AT ASGCT 2026

Reuters·04/27/2026 12:30:01

Please log in to view news